Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Replicative Cell Senescence

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...

Telomeres and Telomerase

Telomeres and Telomerase

In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded DNA.

Telomeres and Telomerase

Telomeres and Telomerase

In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded DNA.

Cancer Stem Cells and Tumor Maintenance

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

Cancer Stem Cells and Tumor Maintenance

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

Replication in Eukaryotes

Replication in Eukaryotes

In eukaryotic cells, DNA replication is highly conserved and tightly regulated. Multiple linear chromosomes must be duplicated with high fidelity before cell division, so there are many proteins that fulfill specialized roles in the replication process. Replication occurs in three phases: initiation, elongation, and termination, and ends with two complete sets of chromosomes in the nucleus.
Many Proteins Orchestrate Replication at the Origin
Eukaryotic replication follows many of the same...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Sulfur amino acids, metabolic health and beyond: Recent advances, translational implications, and future research considerations.

Analytical biochemistry·2025

Same author

Methionine restriction and mimetics to ameliorate human aging and disease.

Trends in endocrinology and metabolism: TEM·2025

Same author

Intermittent methionine restriction and selenium supplementation protect against inflammation and the development of dermatitis.

Journal of inflammation (London, England)·2025

Same author

Intermittent Methionine Restriction Reduces Marrow Fat Accumulation and Preserves More Bone Mass than Continuous Methionine Restriction.

Aging biology·2024

Same author

Intermittent methionine restriction reduces IGF-1 levels and produces similar healthspan benefits to continuous methionine restriction.

Aging cell·2022

Same author

Selenium supplementation inhibits IGF-1 signaling and confers methionine restriction-like healthspan benefits to mice.

eLife·2021

Search research articles

Related Experiment Video

Updated: Jul 14, 2026

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer

Published on: April 13, 2015

Telomere maintenance in sarcomas.

Jay E Johnson¹, Dominique Broccoli

¹Department of Laboratory Oncology Research, Curtis and Elizabeth Anderson Cancer Institute, Memorial Health University Medical Center, Savannah, Georgia 31404, USA.

Current Opinion in Oncology

|June 5, 2007

Summary

Telomere maintenance mechanisms, including telomerase and alternative lengthening of telomeres (ALT), are activated in sarcomas, correlating with tumor progression and poorer patient prognosis. Understanding these pathways is key for developing new sarcoma treatments.

More Related Videos

Telomere Length and Telomerase Activity; A Yin and Yang of Cell Senescence

Telomere Length and Telomerase Activity; A Yin and Yang of Cell Senescence

Published on: May 22, 2013

Generation of Cancer Cell Clones to Visualize Telomeric Repeat-containing RNA TERRA Expressed from a Single Telomere in Living Cells

Generation of Cancer Cell Clones to Visualize Telomeric Repeat-containing RNA TERRA Expressed from a Single Telomere in Living Cells

Published on: January 17, 2019

Related Experiment Videos

Last Updated: Jul 14, 2026

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer

Published on: April 13, 2015

Telomere Length and Telomerase Activity; A Yin and Yang of Cell Senescence

Telomere Length and Telomerase Activity; A Yin and Yang of Cell Senescence

Published on: May 22, 2013

Generation of Cancer Cell Clones to Visualize Telomeric Repeat-containing RNA TERRA Expressed from a Single Telomere in Living Cells

Generation of Cancer Cell Clones to Visualize Telomeric Repeat-containing RNA TERRA Expressed from a Single Telomere in Living Cells

Published on: January 17, 2019

Area of Science:

Oncology
Molecular Biology
Genetics

Background:

Replicative immortality is a hallmark of cancer cells, often achieved through telomere maintenance.
Telomere maintenance mechanisms (TMMs) are crucial for cancer cell survival and proliferation.
Two primary TMMs are telomerase and alternative lengthening of telomeres (ALT).

Purpose of the Study:

To investigate the activation of TMMs in various sarcoma subtypes.
To analyze the impact of TMM activation on genomic stability and tumor progression in sarcomas.
To correlate TMM activation with patient prognosis and tumor characteristics.

Main Methods:

Analysis of sarcoma tissue samples for TMM activation (telomerase and ALT).
Assessment of tumor grade and patient survival data.
Correlation studies between TMM status, tumor characteristics, and clinical outcomes.

Main Results:

A significant proportion of sarcomas exhibit activation of either telomerase or ALT.
ALT is activated as frequently as telomerase, particularly in mesenchymal tumors.
TMM activation, either telomerase or ALT, is strongly associated with tumor progression and poorer patient prognosis.

Conclusions:

Activation of telomere maintenance mechanisms is a key event in sarcoma development and progression.
Both telomerase and ALT activation correlate with unfavorable patient outcomes in sarcomas.
Further research into ALT and telomerase functions may lead to novel therapeutic strategies for sarcomas.